Guru Ownership Trend
Guru Analysis for Anixa Biosciences, Inc. (ANIX)
Anixa Biosciences, Inc. (ANIX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $204,751.89.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $16,718.38 net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 13.6%. Conversely, Steven Cohen reduced exposure by 44.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Anixa Biosciences, Inc. (ANIX)
Major holders include Renaissance Technologies (RenTech) ($157,826), Steven Cohen ($44,572). According to the latest reported data, 2 tracked investment managers collectively hold approximately 78,449 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $16,718.38, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ANIX. The total reported sell value was $35,552.34.
Yes, 0 managers opened new positions in ANIX, and 1 increased their existing holdings. The total reported buy value was $18,833.96.